Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/27/2008 | US20080075698 Brain-Localizing Bone Marrow Progenitor cells |
03/27/2008 | US20080075672 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
03/27/2008 | US20080075662 Novel Method for Analyzing Nucleic Acid Et Use Thereof for Evaluating the Degree of Mrna Editing of the Serotonin 5-Ht2c Receptor |
03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
03/27/2008 | DE102007003670A1 Doubly transgenic nonhuman mammal useful as a lung cancer model has a genome including protooncogene and oncogene sequences |
03/27/2008 | CA2664383A1 Micrornas differentially expressed in pancreatic diseases and uses thereof |
03/27/2008 | CA2664189A1 Compositions and methods related to protein displacement therapy for myotonic distrophy |
03/27/2008 | CA2663962A1 Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
03/27/2008 | CA2663878A1 Mir-200 regulated genes and pathways as targets for therapeutic intervention |
03/27/2008 | CA2663828A1 Binding molecules |
03/27/2008 | CA2663819A1 Phytases, nucleic acids encoding them and methods for making and using them |
03/27/2008 | CA2663812A1 Mir-143 regulated genes and pathways as targets for therapeutic intervention |
03/27/2008 | CA2663803A1 Rnai modulation of scap and therapeutic uses thereof |
03/27/2008 | CA2663755A1 A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator |
03/27/2008 | CA2663709A1 High-throughput electroporation chamber with functional lid for risk reduction |
03/27/2008 | CA2663635A1 Novel genes related to glutaminyl cyclase |
03/27/2008 | CA2663601A1 Duplex oligonucleotide complexes and methods for gene silencing by rna interference |
03/27/2008 | CA2663545A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof |
03/27/2008 | CA2663074A1 Protease resistant insulin analogues |
03/27/2008 | CA2663052A1 Genetically programmed expression of selectively sulfated proteins in eubacteria |
03/27/2008 | CA2663001A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
03/27/2008 | CA2662613A1 Compositions and methods relating to glucagon receptor antibodies |
03/27/2008 | CA2662065A1 Dbait and uses thereof |
03/27/2008 | CA2651881A1 Oligonucleotide analogs having cationic intersubunit linkages |
03/27/2008 | CA2649387A1 Novel gene disruptions, compositions and methods relating thereto |
03/27/2008 | CA2644273A1 Process for the production of a fine chemical |
03/26/2008 | EP1903338A2 Method and Apparatus for Isolating and Purifying Nucleic Acid by Single Bead |
03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
03/26/2008 | EP1903111A2 Extended cDNAs for secreted proteins |
03/26/2008 | EP1903110A2 Micro channel, device for recovering nucleic acid and method for recovering nucleic acid |
03/26/2008 | EP1903108A1 Transmembrane domain-removed recombinant human tyrosinase and method of producing the same |
03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
03/26/2008 | EP1902732A1 Prophylactic/therapeutic agent for her2-expressing cancer |
03/26/2008 | EP1902730A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea |
03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
03/26/2008 | EP1902142A2 3'modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
03/26/2008 | EP1902138A1 Tetrahymena heat inducible promoters and their use |
03/26/2008 | EP1902137A2 High tryptophan soybean meal |
03/26/2008 | EP1902136A2 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
03/26/2008 | EP1902135A1 Plant yield improvement by ste20-like gene expression |
03/26/2008 | EP1902134A2 Plants having increased yield and a method for making the same |
03/26/2008 | EP1902133A2 Spontaneous nodulation in plants |
03/26/2008 | EP1902132A2 Oleosin genes and promoters from coffee |
03/26/2008 | EP1902131A1 Phage display using cotranslational translocation of fusion polypeptides |
03/26/2008 | EP1902129A1 Novel enzymes for use in enzymatic bleaching of food products |
03/26/2008 | EP1902066A2 Il-6 binding proteins |
03/26/2008 | EP1901774A2 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
03/26/2008 | EP1730274A4 Novel modified s-hydroxynitrile lyase |
03/26/2008 | EP1716231A4 Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof |
03/26/2008 | EP1705983A4 Modulation of cytochrome p-450 reductase activity in poppy plants |
03/26/2008 | EP1689886A4 Molecular marker associated with cmv resistance and use thereof |
03/26/2008 | EP1546675A4 Method of measuring molecular interactions |
03/26/2008 | EP1527089B1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
03/26/2008 | EP1465911B1 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
03/26/2008 | EP1458880B1 Isolation tool for viable c-kit expressing cells |
03/26/2008 | EP1458866B1 Modified tridegins, production and use thereof as transglutaminase inhibitors |
03/26/2008 | EP1409693B1 Method for transformation of agaricus bisporus |
03/26/2008 | EP1313873B1 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
03/26/2008 | EP1281068B1 Microphysiometer |
03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
03/26/2008 | EP1189921A4 Synthetic genes for enhanced expression |
03/26/2008 | EP1179068B1 Interleukin-1 hy2 materials and methods |
03/26/2008 | EP1103612B1 Gene participating in the production of homo-glutamic acid and utilization thereof |
03/26/2008 | EP1090128B1 Modified vitamin-k-dependent polypeptides |
03/26/2008 | EP0917535B1 Neuroactive peptide |
03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
03/26/2008 | EP0701605B1 Improved enzymes and detergents containing them |
03/26/2008 | EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
03/26/2008 | CN101151378A Predermined site luminescence measuring method, predetermined site luminenscence measuring apparatus, expression amount measuring method, and measuring apparatus |
03/26/2008 | CN101151373A Elite event A2704-12 and methods and kits for identifying such event in biological samples |
03/26/2008 | CN101151372A Protein and its use in diagnosing alzheimer's disease |
03/26/2008 | CN101151371A Retrotransposon inhibition in therapy |
03/26/2008 | CN101151370A Reaction vessel, reaction vessel processing apparatus and diagnostic apparatus |
03/26/2008 | CN101151369A Dipeptide crystals and process for production thereof |
03/26/2008 | CN101151368A Gene expression cassette and transformant, and process for production of 2-deoxy-scyllo-inosose and process for purification of 2-deoxy-scyllo-inosose using the transformant |
03/26/2008 | CN101151367A Methods of refolding mammalian glycosyltranferases |
03/26/2008 | CN101151366A In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
03/26/2008 | CN101151363A Plant virus designated tomato torrado virus |
03/26/2008 | CN101151276A Method of producing protein by using hamster IGF-1 |
03/26/2008 | CN101151272A Recombinant icosahedral virus like particle production in pseudomonads |
03/26/2008 | CN101148681A Targeted coexpression p53 and Mda-7 recombination adenovirus |
03/26/2008 | CN101148680A Method for leading plasmid carrier containing gene cure segment in cell by nano particles |
03/26/2008 | CN101148679A Extraneous sources IPTG and O2 concentration simultaneously regulating and controlling expression carrier and construction method thereof |
03/26/2008 | CN101148678A Human papilloma virus vaccine and preparation method thereof |
03/26/2008 | CN101148677A Method for fast extracting AM epiphyte environment DNA in plant rhizosphere soil |
03/26/2008 | CN101148676A Method for constructing mangrove forest soil large section metagenome library |
03/26/2008 | CN101148675A Inhibin protein for inducing plant to resist disease and accelerate growth and gene sequence |
03/26/2008 | CN101148674A Clone and application of pleiotropy gene Ghd7 used for controlling rice grain production, ear sprouting period and plant height |
03/26/2008 | CN101148673A Soybean abloom time adjusting gene GAL1 |
03/26/2008 | CN101148672A Soybean abloom time adjusting gene GAL2 and application thereof |
03/26/2008 | CN101148671A Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof |
03/26/2008 | CN101148670A Preparation for breast cancer monoclonal antibody M4G3 single-chain antibody and DNA sequence thereof |
03/26/2008 | CN101148669A Multi-copy beefy meaty peptide expression gene and carrier, and recombination Pichia pastoris construction |
03/26/2008 | CN101148668A Clone for pork generation character related gene BTG1 of pig and application thereof in pig molecule mark auxiliary selection |
03/26/2008 | CN101148667A Preparation and use for affinity human albumin nucleic acid aptamer |
03/26/2008 | CN101148666A Nucleic acid aptamer with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof |